Tema Heart & Health ETF Rating $28.00 +0.15 (+0.54%) As of 08/1/2025 03:32 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Heart & Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.76Holdings in HRTS have an aggregate rating of Moderate Buy based on 648 analyst ratings issued in the past year covering 39 companies (83.4% of the portfolio).HRTS Aggregate Price Target$28.00High Prediction$28.00Average Prediction$28.00Low Prediction$28.00Holdings in HRTS have an aggregate price target of $28.00 and a range of $28.00 to $28.00 covering 39 companies (83.4% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy24 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Heart & Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 39 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.76%LLYEli Lilly and Company$761.47+2.9%4.9115 of 5 stars2.75$1,012.56 33.0%20Trending NewsUpcoming Earnings4.54%ABTAbbott Laboratories$127.32+0.9%4.983 of 5 stars2.91$144.47 13.5%22Positive News4.17%RHHBYRoche$38.84-0.2%N/A2.577Gap Down3.84%BBIOBridgeBio Pharma$47.37+0.2%4.7123 of 5 stars3.00$61.18 29.1%17Upcoming EarningsAnalyst Forecast3.65%UNHUnitedHealth Group$237.40-4.9%4.9919 of 5 stars2.50$373.52 57.3%24Trending NewsEarnings ReportAnalyst ForecastOptions VolumeAnalyst RevisionHigh Trading Volume3.49%BSXBoston Scientific$105.40+0.5%4.5367 of 5 stars3.04$117.50 11.5%26Trending NewsInsider Trade3.24%VRTXVertex Pharmaceuticals$462.13+1.2%4.3421 of 5 stars2.50$509.89 10.3%26Positive NewsUpcoming EarningsShort Interest ↑3.16%GILDGilead Sciences$113.18+0.8%4.6334 of 5 stars2.81$112.36 -0.7%26Positive NewsUpcoming EarningsInsider Trade3.02%MDTMedtronic$89.31-1.0%4.5626 of 5 stars2.59$98.19 9.9%22Positive News2.68%TMOThermo Fisher Scientific$462.74-1.1%4.9941 of 5 stars2.71$593.00 28.1%21Positive NewsAnalyst Upgrade2.60%AMGNAmgen$296.88+0.6%4.5139 of 5 stars2.35$307.27 3.5%23Positive NewsUpcoming EarningsDividend Announcement2.59%CRNXCrinetics Pharmaceuticals$27.84-2.6%3.3272 of 5 stars2.80$69.50 149.6%10News CoverageUpcoming Earnings2.53%MRKMerck & Co., Inc.$79.27+1.5%4.997 of 5 stars2.35$107.44 35.5%20Trending NewsEarnings ReportAnalyst ForecastOptions VolumeAnalyst Revision2.26%ABBVAbbVie$195.17+3.3%4.5744 of 5 stars2.81$212.81 9.0%27Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.17%EWEdwards Lifesciences$79.300.0%4.4846 of 5 stars2.65$85.71 8.1%26Analyst Upgrade2.14%ALNYAlnylam Pharmaceuticals$401.80+2.4%3.8639 of 5 stars2.81$392.13 -2.4%26Trending NewsAnalyst Forecast2.12%PODDInsulet$284.91-1.2%4.6076 of 5 stars2.83$321.00 12.7%18News CoveragePositive NewsUpcoming Earnings2.08%REGNRegeneron Pharmaceuticals$558.87+2.5%4.9101 of 5 stars2.75$828.86 48.3%24Trending NewsAnalyst ForecastGap Up2.08%BMYBristol Myers Squibb$44.25+2.2%4.8702 of 5 stars2.38$57.33 29.6%21Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.05%DHRDanaher$197.080.0%4.9705 of 5 stars2.85$247.61 25.6%20Positive News1.91%MCKMcKesson$698.43+0.7%4.5174 of 5 stars2.86$710.17 1.7%14Positive NewsUpcoming EarningsDividend Increase1.69%IONSIonis Pharmaceuticals$43.03+0.1%4.5458 of 5 stars2.86$59.38 38.0%14Trending NewsEarnings ReportAnalyst ForecastInsider Trade1.61%CYTKCytokinetics$36.69-2.5%4.0943 of 5 stars2.88$70.92 93.3%16News CoverageUpcoming EarningsAnalyst ForecastInsider Trade1.49%DXCMDexCom$79.28-1.8%4.9727 of 5 stars2.95$99.89 26.0%22Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst Revision1.38%ASNDAscendis Pharma A/S$174.48+0.6%3.0792 of 5 stars3.00$223.67 28.2%15Analyst Forecast1.32%MASIMasimo$153.95+0.1%3.6862 of 5 stars2.83$191.60 24.5%6Positive NewsUpcoming Earnings1.17%ARWRArrowhead Pharmaceuticals$15.93+0.8%3.8355 of 5 stars2.89$43.71 174.4%9News CoverageUpcoming Earnings1.07%VKTXViking Therapeutics$32.68+0.3%3.8708 of 5 stars3.00$86.92 166.0%14Short Interest ↑1.06%MDGLMadrigal Pharmaceuticals$302.17-0.1%4.2783 of 5 stars2.89$420.63 39.2%9News CoverageUpcoming Earnings1.04%AKROAkero Therapeutics$48.37-1.0%3.9559 of 5 stars3.00$82.50 70.6%6Positive NewsUpcoming Earnings0.95%MIRMMirum Pharmaceuticals$52.02+0.7%3.7255 of 5 stars3.13$65.50 25.9%8News CoveragePositive NewsUpcoming Earnings0.92%INSMInsmed$108.69+1.3%3.8031 of 5 stars3.00$109.20 0.5%17Positive NewsUpcoming Earnings0.91%GPCRStructure Therapeutics$17.59-1.2%2.0602 of 5 stars3.00$76.17 333.0%7News CoverageUpcoming Earnings0.85%WSTWest Pharmaceutical Services$239.150.0%4.6202 of 5 stars2.89$320.71 34.1%9Positive NewsShort Interest ↑0.72%SRRKScholar Rock$36.36-1.9%3.8123 of 5 stars3.22$44.14 21.4%9News CoveragePositive NewsUpcoming EarningsAnalyst Forecast0.35%MREOMereo BioPharma Group$1.66-1.8%1.3786 of 5 stars3.20$7.20 333.7%50.34%NTLAIntellia Therapeutics$11.49-1.3%4.584 of 5 stars2.65$33.37 190.4%20News CoverageUpcoming EarningsGap Down0.31%MTSRMetsera$34.89+5.8%N/A3.00$55.00 57.6%5News CoverageEarnings ReportLockup ExpirationAnalyst RevisionGap Down0.18%RCKTRocket Pharmaceuticals$2.99-2.0%4.8355 of 5 stars2.35$17.87 497.5%17Trending NewsUpcoming Earnings This page (NASDAQ:HRTS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts